{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T17:10:05Z","timestamp":1756314605114,"version":"3.44.0"},"reference-count":21,"publisher":"BMJ","issue":"6","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2021,5,14]]},"published-print":{"date-parts":[[2021,6]]},"abstract":"<jats:p>Postoperative cystoid macular oedema (CMO) is a recognised complication of cataract surgery, occurring in around 1.5% of cases. It is generally managed with topical steroids or non-steroidal anti-inflammatory medications. We present a case of a patient who developed bilateral sequential CMO following bilateral sequential cataract surgery which was non-responsive to topical therapy and worsened following sub-Tenons administration of steroid. The patient took fingolimod for multiple sclerosis both prior to and during the period of cataract surgery which is known to result in the development of macular oedema in some patients. On fingolimod cessation, the oedema resolved over a period of 5 months with good visual recovery. We present this case to inform cataract surgeons of the risk of fingolimod-associated macular oedema in patients undergoing cataract surgery and to inform neurologists of the potential need to adjust treatment for patients undergoing cataract surgery.<\/jats:p>","DOI":"10.1136\/bcr-2020-240562","type":"journal-article","created":{"date-parts":[[2021,6,4]],"date-time":"2021-06-04T11:11:12Z","timestamp":1622805072000},"page":"e240562","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Bilateral fingolimod-associated macular oedema development after cataract surgery"],"prefix":"10.1136","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8503-600X","authenticated-orcid":false,"given":"Matthew","family":"Gillam","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Imperial College Healthcare NHS Trust, London, UK"},{"name":"Moorfields Eye Hospital NHS Foundation Trust, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theresa","family":"Richardson","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Imperial College Healthcare NHS Trust, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2021,6,4]]},"reference":[{"key":"2025082709382783000_14.6.e240562.1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.eye.6703015"},{"key":"2025082709382783000_14.6.e240562.2","doi-asserted-by":"crossref","first-page":"919","DOI":"10.2147\/OPTH.S4033","article-title":"Cystoid macular edema","volume":"2","author":"Rotsos","year":"2008","journal-title":"Clin Ophthalmol"},{"key":"2025082709382783000_14.6.e240562.3","unstructured":"European medicines agency, 2019. Available: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/gilenya"},{"key":"2025082709382783000_14.6.e240562.4","first-page":"2912","article-title":"Fty720 versus MMF with cyclosporine in de novo renal transplantation: a 1-year","volume":"6","author":"Salvadori","year":"2006","journal-title":"randomized controlled trial in Europe and Australasia: Am J Transpl"},{"key":"2025082709382783000_14.6.e240562.5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0907839"},{"key":"2025082709382783000_14.6.e240562.6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0909494"},{"key":"2025082709382783000_14.6.e240562.7","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/eye.2016.258","article-title":"Fingolimod: therapeutic mechanisms and ocular adverse effects","volume":"31","author":"Mandal","year":"2017","journal-title":"Eye"},{"key":"2025082709382783000_14.6.e240562.8","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/ceo.13513","article-title":"Cystoid macular oedema following cataract surgery: a review","volume":"47","author":"Han","year":"2019","journal-title":"Clin Exp Ophthalmol"},{"key":"2025082709382783000_14.6.e240562.9","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ajoc.2016.09.005","article-title":"Acute onset of fingolimod-associated macular edema","volume":"4","author":"Soliman","year":"2016","journal-title":"Am J Ophthalmol Case Rep"},{"key":"2025082709382783000_14.6.e240562.10","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17122106","article-title":"Fingolimod associated bilateral cystoid macular Edema\u2014Wait and see?","volume":"17","author":"Pul","year":"2016","journal-title":"Int J Mol Sci"},{"key":"2025082709382783000_14.6.e240562.11","article-title":"Postoperative cystoid macular oedema in a patient on fingolimod","volume":"2015","author":"Gaskin","year":"2015","journal-title":"BMJ Case Rep"},{"key":"2025082709382783000_14.6.e240562.12","doi-asserted-by":"publisher","DOI":"10.1212\/CPJ.0000000000000027"},{"key":"2025082709382783000_14.6.e240562.13","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.2147\/OPTH.S132810","article-title":"Topical nepafenac for prevention of post-cataract surgery macular edema in diabetic patients: patient selection and perspectives","volume":"11","author":"Y\u00fcksel","year":"2017","journal-title":"Clin Ophthalmol"},{"key":"2025082709382783000_14.6.e240562.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2012.12.040"},{"key":"2025082709382783000_14.6.e240562.15","doi-asserted-by":"crossref","first-page":"323","DOI":"10.5935\/0004-2749.20180063","article-title":"Effects of sub-Tenon's triamcinolone injections in patients with uveitis","volume":"81","author":"Ferreira","year":"2018","journal-title":"Arq Bras Oftalmol"},{"key":"2025082709382783000_14.6.e240562.16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-9071.1988.tb01241.x"},{"key":"2025082709382783000_14.6.e240562.17","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2415-6-15"},{"key":"2025082709382783000_14.6.e240562.18","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(97)30065-7"},{"key":"2025082709382783000_14.6.e240562.19","doi-asserted-by":"publisher","DOI":"10.1016\/S0886-3350(03)00233-5"},{"key":"2025082709382783000_14.6.e240562.20","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0002-9394(14)76851-5","article-title":"Improvement in visual acuity in chronic aphakic and pseudophakic cystoid macular edema after treatment with topical 0.5% ketorolac tromethamine","volume":"112","author":"Flach","year":"1991","journal-title":"Am J Ophthalmol"},{"key":"2025082709382783000_14.6.e240562.21","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1159\/000430087","article-title":"A case of acute bilateral Irvine-Gass syndrome following uncomplicated phacoemulsification, demonstrated with optical coherence tomography","volume":"6","author":"Shields","year":"2015","journal-title":"Case Rep Ophthalmol"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2020-240562","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T16:38:36Z","timestamp":1756312716000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2020-240562"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":21,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,6,4]]},"published-print":{"date-parts":[[2021,6]]}},"alternative-id":["10.1136\/bcr-2020-240562"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2020-240562","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2021,6]]}}}